Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.

about

The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients.

P2860

Q40051750-C8EE24E0-8FEA-4B05-BE84-E860ACD5E657 Q42235935-C85C8B2C-732D-4EBA-BC12-797F14F7BF59

P2860

Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.

Item

http://www.wikidata.org/entity/Q42994597

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Evaluation of five screening t ...... hepatitis C virus antibodies.

@en

Evaluation of five screening t ...... hepatitis C virus antibodies.

@nl

type

Item

label

Evaluation of five screening t ...... hepatitis C virus antibodies.

@en

Evaluation of five screening t ...... hepatitis C virus antibodies.

@nl

prefLabel

Evaluation of five screening t ...... hepatitis C virus antibodies.

@en

Evaluation of five screening t ...... hepatitis C virus antibodies.

@nl

P1476

Evaluation of five screening t ...... hepatitis C virus antibodies.

@en

P2093

Claudia Domínguez

http://www.w3.org/2001/XMLSchema#string

Elena Treviño

http://www.w3.org/2001/XMLSchema#string

Gabriela Barbás

http://www.w3.org/2001/XMLSchema#string

Héctor Bepre

http://www.w3.org/2001/XMLSchema#string

Marta Contigiani

http://www.w3.org/2001/XMLSchema#string

Osvaldo Elbarcha

http://www.w3.org/2001/XMLSchema#string

Sandra Gallego

http://www.w3.org/2001/XMLSchema#string

Viviana Ré

http://www.w3.org/2001/XMLSchema#string

P2860

NAT of the United States and Canadian blood supply.

Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy.

Current and future hepatitis C virus diagnostic testing: problems and advancements.

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.

The declining risk of post-transfusion hepatitis C virus infection.

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

Efficacy of HCV core antigen detection during the preseroconversion period.

Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.

Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks?

P304

303-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0074-02762005000300016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16113873

http://www.w3.org/2001/XMLSchema#string

P921

Argentina

Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.

about

P2860

P2860

Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921